About ISSX

The International Society for the Study of Xenobiotics (ISSX) was founded to advance research and education on the interplay of living systems with medicines and chemicals for the benefit of society worldwide.

We are an international base of 1,100 members from more than 45 countries. Members are comprised fairly evenly between academic and industry groups and consist primarily of research scientists and future scientists in toxicology, pharmacology, molecular biology, and other disciplines related to the study of xenobiotics.

As the foremost organization representing the interests of researchers and educators in DMPK (Drug Metabolism and Pharmacokinetics) and other related areas of research, ISSX is engaged in multiple activities to support, promote, and advance the science worldwide.

Why Exhibit with ISSX?

Interact with a broad representation of international researchers and other scientists who are gaining a deeper understanding of drug metabolism and pharmacokinetics. Your partnership and solutions can help make the world a better place!

Your exhibit with ISSX opens the door for you to interact with key decision makers with purchasing power in academia and industry as well as scientists in government, CROs, and consulting.

ISSX Attendees.png

ISSX International Meetings
by the Numbers

Attendees: 1,000

Poster Presentations: 500

Scientific Sessions: 22

Industry Attendees

  • Account Manager

  • Associate Director

  • Business Development Director

  • Chief Executive Officer

  • Chief Business Officer

  • Director

  • Senior Scientist

  • President

  • Vice President

Academic Attendees

  • Assistant Professor

  • Associate Chair

  • Associate Dean

  • Associate Professor

  • Department Chair

  • Professor

  • Postdoctoral Fellow

  • Research Advisor

  • Research Fellow